DKA: Transitioning From the Insulin Drip to Subcutaneous Insulin

Part of the ICU Pharmacology Hub — browse every related guide in one place.

Updated July 2026  |  More ICU nursing guides →

The insulin drip is the easy part of diabetic ketoacidosis. The transition off it is where patients bounce back into the ICU. Stop the infusion an hour too early or without overlapping subcutaneous insulin and you can send a patient straight back into ketoacidosis, because IV regular insulin has a half-life measured in minutes. This is an ICU nursing guide to the handoff that ends a DKA admission cleanly instead of restarting it.

First: is the DKA actually resolved?

The transition is driven by resolution of ketoacidosis, not by the glucose number. This is the single most misunderstood point at the bedside. A patient's glucose can normalize within hours while the underlying acidosis is still open — which is exactly why DKA protocols add dextrose to the fluids and keep the insulin running once glucose falls, rather than stopping insulin. Insulin is what shuts off ketone production; you keep it going until the acid is gone.

Commonly used resolution criteria (confirm yours) require roughly two of the following:

The anion gap is the workhorse. Watch its trend across the chemistry panels — a closing gap is the clearest sign the acidosis is clearing. Glucose alone tells you almost nothing about whether it's safe to stop the drip.

The overlap window is non-negotiable

Here is the rule that prevents rebound DKA: give the subcutaneous long-acting (basal) insulin before you stop the infusion, and let them overlap. Subcutaneous glargine or detemir takes roughly 1–2 hours to begin working and doesn't reach steady coverage immediately. IV insulin disappears within minutes of stopping. If you turn off the drip the moment you give the basal dose, you create a coverage gap — a window with no effective insulin on board — and ketogenesis restarts.

What the subcutaneous regimen looks like

Most patients transition to a basal-bolus regimen: a long-acting basal insulin plus rapid-acting insulin with meals, and a correction (sliding) scale on top. For a patient with known home insulin needs, the team often resumes a version of their prior regimen. For a newly diagnosed or insulin-naive patient, the total daily dose is commonly estimated — sometimes weight-based, sometimes derived from the last several hours of drip requirements extrapolated over 24 hours, with a portion held back as a safety buffer. Roughly half the total daily dose is given as basal and half split across meals. You don't set these numbers, but knowing the logic helps you catch an order that looks off for the patient in front of you.

Timing it around meals and the clock

The cleanest transitions are planned, not reactive. Ideally the basal dose is timed so the patient can eat afterward and receive mealtime insulin, and the changeover happens when staffing supports close glucose monitoring — not at 0300 during a handoff. If a patient still can't eat, the basal insulin still goes (basal covers background needs regardless of intake), but mealtime doses are held or adjusted. Coordinate with the provider so the plan matches the patient's ability to eat.

After the drip is off: watch closely

The first 12–24 hours after discontinuation are when problems surface. Expect frequent fingersticks (often q1–2h initially, then spacing out per protocol), and be alert for two failure modes: rebound hyperglycemia/ketosis from an insufficient or late basal dose (rising glucose, recurring gap — escalate early), and hypoglycemia from stacking correction doses onto a basal that's still ramping. Keep monitoring potassium as well; insulin drives K+ intracellularly, and shifts continue after the transition. Don't consider the DKA "done" until the patient is stable on subcutaneous insulin and tolerating intake.

The nursing bottom line

Transition off the insulin drip only when the acidosis has resolved — track the anion gap and bicarbonate, not just the glucose. Give the subcutaneous basal insulin 1–2 hours before stopping the infusion so the two overlap and there's never a gap in coverage. Time it so the patient can eat and be monitored closely, keep watching glucose and potassium for the next day, and treat rising glucose with a widening gap as a red flag for an inadequate transition. Get the overlap right and DKA ends; skip it and it starts over.

Related: CAM-ICU delirium assessment, ICU sepsis protocol, lactate clearance in sepsis, and cisatracurium (Nimbex) guide.